This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In their article, Strebel and colleagues¹ report a systematic review assessing the relative efficacy and safety of low-molecular-weight heparins used to prevent thrombosis after total hip replacement. The authors comment that for the double-blind North American Fragmin Trial (NAFT),² "This relatively low incidence of thrombosis is offset by a relatively high rate of major bleeding of 8.8% in the early preoperative group and 6.8% in the early postoperative group."¹ The authors further note that "The rates of bleeding in both of these perioperative groups are higher" than their pooled preoperative and postoperative data or the perioperative data reported by Planes et al³ and Francis et al.⁴

It is important to note that NAFT was double-blind and reported bleeding rates separately based on centrally adjudicated major bleeding; site investigator–classified major bleeding; and site investigator–classified serious bleeding. Strebel et al¹ have failed to include or comment on the site investigator–classified major and . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Reporting the NAFT Major Bleeding Rates in Context: Reviewers Should Include Site Investigator–Classified Rates
Niklaus Strebel, Martin H. Prins, and Harry R. Büller
Arch Intern Med. 2003;163(3):369.
EXTRACT | FULL TEXT  

Preoperative or Postoperative Start of Prophylaxis for Venous Thromboembolism With Low-Molecular-Weight Heparin in Elective Hip Surgery?
Niklaus Strebel, Martin Prins, Giancarlo Agnelli, and Harry R. Büller
Arch Intern Med. 2002;162(13):1451-1456.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

State-of-the-Art Review: Assessing the Safety Profiles of New Anticoagulants for Major Orthopedic Surgery Thromboprophylaxis
Hull et al.
CLIN APPL THROMB HEMOST 2009;15:377-388.
ABSTRACT